Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
The Journal of Urology|June 17, 1998
Camptothecin analogues/cisplatin: an effective treatment of advanced bladder cancer in a preclinical in vivo model systemT E Keane, R E El-Galley, C Sun, et al.
Urology|January 1, 1995
Intravesical suramin in the prevention of transitional cell carcinomaS D Graham, P Napalkov, A Oladele, et al.
Urology|August 1, 1995
Normal range prostate-specific antigen versus age-specific prostate-specific antigen in screening prostate adenocarcinomaR E el-Galley, J A Petros, W H Sanders, et al.
The American Journal of Pathology|February 10, 2000
Loss of FHIT expression in transitional cell carcinoma of the urinary bladderR Baffa, L G Gomella, A Vecchione, et al.
Archives of Surgery (Chicago, Ill. : 1960)|July 1, 1991
Randomized study of interleukin 2 (IL-2) alone vs IL-2 plus lymphokine-activated killer cells for treatment of melanoma and renal cell cancerM J Koretz, D H Lawson, R M York, et al.
Physical Review Letters|May 28, 2021
Roton Excitations in an Oblate Dipolar Quantum GasJ-N Schmidt, J Hertkorn, M Guo, et al.
Urology|May 1, 1993
Staging of early prostate cancer: a proposed tumor volume-based prognostic indexD G Bostwick, S D Graham, P Napalkov, et al.
AJR. American Journal of Roentgenology|January 1, 1985
CT-guided adrenal biopsy: accuracy, safety, and indicationsM E Bernardino, M M Walther, V M Phillips, et al.
Physical Review Letters|October 22, 2021
Supersolidity in Two-Dimensional Trapped Dipolar Droplet ArraysJ Hertkorn, J-N Schmidt, M Guo, et al.
Oncogene|September 22, 2015
The mRNA-binding protein HuR promotes hypoxia-induced chemoresistance through posttranscriptional regulation of the proto-oncogene PIM1 in pancreatic cancer cellsF F Blanco, M Jimbo, J Wulfkuhle, et al.
Pageof 11